Additional Proxy Soliciting Materials (definitive) (defa14a)
April 15 2019 - 4:19PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 14A
(Rule
14a-101)
Information Required in Proxy Statement
Schedule 14A Information
Proxy Statement Pursuant to Section 14(a) of the
Securities Exchange Act of 1934
(Amendment No. )
Filed by the Registrant
☒ Filed by a party other than the Registrant
☐
Check the appropriate box:
|
|
|
☐
|
|
Preliminary Proxy Statement
|
|
|
☐
|
|
Confidential, for Use of the Commission Only (as permitted by Rule
14a-6(e)(2))
|
|
|
☐
|
|
Definitive Proxy Statement
|
|
|
☒
|
|
Definitive Additional Materials
|
|
|
☐
|
|
Soliciting Material Pursuant to
§240.14a-12
|
Achillion Pharmaceuticals, Inc.
(Name of Registrant as Specified In Its Charter)
(Name of Person(s) Filing Proxy Statement, if other than the Registrant)
Payment of Filing Fee (Check the appropriate box):
|
|
|
|
|
|
|
☒
|
|
No fee required.
|
|
|
☐
|
|
Fee computed on table below per Exchange Act Rules
14a-6(i)(1)
and
0-11.
|
|
|
|
|
|
(1)
|
|
Title of each class of securities to which transaction applies:
|
|
|
(2)
|
|
Aggregate number of securities to which transaction applies:
|
|
|
(3)
|
|
Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule
0-11
(set forth the amount on which the filing fee is calculated and state how it was determined):
|
|
|
(4)
|
|
Proposed maximum aggregate value of transaction:
|
|
|
(5)
|
|
Total fee paid:
|
|
|
☐
|
|
Fee paid previously with preliminary materials.
|
|
|
☐
|
|
Check box if any part of the fee is offset as provided by Exchange Act Rule
0-11(a)(2)
and identify the filing for which the offsetting fee was paid previously. Identify the
previous filing by registration statement number, or the Form or Schedule and the date of its filing.
|
|
|
|
|
|
(1)
|
|
Amount previously paid:
|
|
|
(2)
|
|
Form, Schedule or Registration Statement No.:
|
|
|
(3)
|
|
Filing party:
|
|
|
(4)
|
|
Date Filed:
|
*** Exercise Your
Right
to Vote ***
Important Notice Regarding the Availability of Proxy Materials for the
Stockholder Meeting to Be Held on May 30, 2019.
|
|
|
ACHILLION
PHARMACEUTICALS, INC.
|
|
|
|
|
ACHILLION PHARMACEUTICALS, INC.
1777 SENTRY PARKWAY WEST
BUILDING 14, SUITE 200
BLUE BELL, PA 19422
|
|
|
|
|
|
|
Meeting Information
|
Meeting Type:
Annual Meeting
|
For holders as of:
April 2, 2019
|
Date:
May 30, 2019
Time:
9:00 AM Eastern Time
|
Location:
Meeting live via the Internet-please visit
|
www.virtualshareholdermeeting.com/ACHN2019.
The company will be hosting the meeting live via the Internet this year. To attend the meeting via the
Internet please visit www.virtualshareholdermeeting.com/ACHN2019 and be sure to have the information that is printed in the box marked by the arrow
(located on the following page).
|
You are receiving this communication because you hold shares in the company named above.
This is not a ballot. You cannot use this notice to vote these shares. This communication presents only an overview of the more complete proxy materials
that are available to you on the Internet. You may view the proxy materials online at
www.proxyvote.com
or easily request a paper copy (see reverse side).
We encourage you to access and review all of the important information contained in the proxy materials before voting.
|
See the reverse side of this notice to obtain proxy materials and voting instructions.
|
Before You Vote
How to Access the Proxy Materials
|
|
|
|
|
|
|
|
|
|
|
Proxy
Materials Available to VIEW or RECEIVE:
|
|
|
|
|
|
|
NOTICE AND PROXY STATEMENT ANNUAL REPORT
|
|
|
|
|
|
|
How to View Online:
Have the information that is printed in the box marked by the arrow
(located on the following page)
and visit:
www.proxyvote.com.
How to Request and Receive a PAPER or
E-MAIL
Copy:
If you want to receive a paper or e-mail copy of these documents, you must request one. There is NO charge for requesting a copy. Please choose one of the following methods to make your
request:
|
|
|
|
|
1)
BY INTERNET
: www.proxyvote.com
|
|
|
|
|
|
|
2)
BY TELEPHONE
: 1-800-579-1639
|
|
|
|
|
|
|
3)
BY E-MAIL*
: sendmaterial@proxyvote.com
|
|
|
|
|
|
|
* If requesting materials by
e-mail,
please send a blank
e-mail
with the information that is printed in the box
marked by the arrow
(located on the following page) in the subject line.
|
|
|
|
|
Requests, instructions and other inquiries sent to this e-mail address will NOT be forwarded to your investment advisor. Please make the request as
instructed above on or before May 16, 2019 to facilitate timely delivery.
|
|
|
How To Vote
Please Choose One of the Following Voting Methods
|
|
|
|
|
|
|
|
|
|
Vote By Internet:
Before The Meeting:
Go to
www.proxyvote.com.
Have the information that is printed in the box marked by the arrow
(located on the following page) available and follow the instructions.
During
The Meeting:
Go to
www.virtualshareholdermeeting.com/ACHN2019.
Have the information that is printed in the box
marked by the arrow
(located on the following page) available and follow the instructions.
|
|
|
|
|
Vote By Mail:
You can
vote by mail by requesting a paper copy of the materials, which will include a proxy card.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Voting Items
|
|
|
|
|
|
|
The Board of Directors
recommends you vote FOR
all the nominees listed in proposal 1:
1. To elect three Class I Directors for terms to expire
at our 2022 annual meeting of stockholders
or until their successors are duly elected
and
qualified.
Nominees:
01) Kurt Graves
02) David I. Scheer
03) Frank Verwiel, M.D.
The Board of Directors recommends you vote FOR proposals 2, 3 and 4:
2. To approve, on an advisory
basis, our executive compensation.
3. To approve an amendment to our amended and restated certificate of
incorporation to increase the number of shares of common stock, par value $0.001 per share, authorized for issuance from 200,000,000 to 300,000,000.
4. To ratify the selection of PricewaterhouseCoopers LLP as our independent registered public
accounting firm for the current fiscal year.
Note:
To transact such other business as may properly come before the meeting or any adjournment thereof.
|
|
|
|
|
|
Achillion Pharmaceuticals (NASDAQ:ACHN)
Historical Stock Chart
From Aug 2024 to Sep 2024
Achillion Pharmaceuticals (NASDAQ:ACHN)
Historical Stock Chart
From Sep 2023 to Sep 2024